2012 AACR: SGI-110, a novel SQ second generation DNA hypomethylating agent

2012 AACR: SGI-110, a novel SQ second generation DNA hypomethylating agent

2012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110

2012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110

2011 TAT_Discovery and Development of Next Generation Epigenetic DNMT Inhibitor SGI-110

2011 TAT_Discovery and Development of Next Generation Epigenetic DNMT Inhibitor SGI-110

2010 AACR J_S110 is Effective DNA Methylation Inhibitor In vivo and Reduces Tumor Growth

2010 AACR J_S110 is Effective DNA Methylation Inhibitor In vivo and Reduces Tumor Growth

2010 ASH_SGI-110 Preclinical, PK, DNA Methylation of Low Vol Subcutaneous Formulation

2010 ASH_SGI-110 Preclinical, PK, DNA Methylation of Low Vol Subcutaneous Formulation

2008 ASH_Anti-AML Activity of SGI-110 and SGI-1036, panobinostat Combined Therapy

2008 ASH_Anti-AML Activity of SGI-110 and SGI-1036, panobinostat Combined Therapy

2008 EORTC_In Vivo Activity of SGI-110, a Novel Hypomethylating Agent

2008 EORTC_In Vivo Activity of SGI-110, a Novel Hypomethylating Agent